Business Description
Celyad Oncology SA is a Belgian biotechnology company founded in 2004 and based in Mont-Saint-Guibert. The company owns a portfolio of key US patents covering T cell-based cancer treatments designed to work across different patients without requiring a personal match. Its work centers on developing and licensing these cell therapy innovations to advance the fight against cancer.
